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Abstract Exposure of human blood monocytes derived macro-
phages to modified (oxidized or acetylated) LDL induced a 
~40% elevation (60 pmol/106 cells) of the endogenous level of 
the sphingolipid ceramide. A rise of both neutral and acidic 
SMase activity was found after treatment with oxidized LDL 
(250 and 80%), while addition of acLDL stimulated only the 
neutral enzyme (280%). Sphingo(phospho)lipids from LDL were 
transferred to the cell membrane and distributed into intracel-
lular compartments as observed with acLDL containing BOD-
IPY-FL-C5-SM. Quantitation of ceramide after the addition of 
|3H-7V-acetyll- or BODIPY-FL-C5-SM-labeled modified LDL 
(27 Hg/ml) to the cell culture medium indicated that approxi-
mately 210 pmol CA/106 cells was generated from exogenous 
(ox/acLDL) SM. These results demonstrate a stimulation of the 
sphingomyelin-ceramide pathway by modified LDL utilizing 
primarily exogenous (LDL-derived) substrate and suggest that 
the effects of modified LDL are at least partially due to an 
increased level of the messenger ceramide. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Low density lipoprotein (LDL) is a (phospho)lipid-protein 
complex susceptible to oxidation which is generally considered 
to play a critical role in atherogenesis [1,2]. In plasma, the 
lipoprotein is an important carrier of phospholipids and neu-
tral lipids. Exposure of monocytes/macrophages to LDL, in 
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Abbreviations: acLDL, acetylated low density lipoprotein; BODIPY-
FL-C5-SM, JV-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-inda-
cene-3-pentanoyl)-sphingosylphosphocholine/sphingomyelin; BODI-
PY-FL-C5-CA, JV-(4,4-difluoro-5,7-dimetriyl-4-bora-3a,4a-diaza-s-
indacene-3-pentanoyl)-sphingosine/ceramide; CA, ceramide; C2-CA, 
/V-acetyl-ceramide, 7V-acetyl-D-erythrosphingosine; DAG, diacyl-
glycerol; EC, human umbilical endothelial cell(s); EC-LDL, LDL 
oxidized by endothelial cells ; HBMC, human blood monocytes derived 
macrophages; oxLDL, oxidized LDL; PBS, phosphate-buffered 
sodium chloride solution; SM, JV-acylsphingosin-1-phosphocholine, 
sphingomyelin; SMase, sphingomyelinase(s), sphingomyelin phospho-
diesterase; TLC, thin-layer chromatography 
particular to chemically or oxidatively modified lipoprotein, 
causes a variety of biological effects and provokes a complex 
assembly of cellular responses including activation of distinct 
signal transduction pathways [3-6]. Among other phospholi-
pids, LDL contains a considerable amount of sphingomyelin 
(SM) [7]. Ceramide (CA) generated by SM hydrolysis is in-
creasingly recognized as an important mediator implicated in 
a variety of physiological processes such as cell growth, differ-
entiation, and apoptosis [8,9]. The SM-CA pathway repre-
sents a route to transduce signals from cell surface receptors 
to the nucleus utilizing the diffusible lipid CA as a messenger 
[10,11]. Signal transduction in cells is induced by the hydrol-
ysis of SM located in the plasma membrane, by a SM-specific 
phospholipase C, sphingomyelinase (SMase). Two forms of 
this enzyme are distinguishable by their acidic or basic pH 
optimum (review in [12]). 
Although many mechanisms in the concert of cellular 
events induced by LDL and modified LDL have so far re-
mained unclear, several effects could be assigned to lipid and 
phospholipid components of the particle [13]. We therefore 
reasoned that exogenous SM provided by LDL/modified 
LDL may affect the intracellular SM/CA pool in macrophages 
and may also alter concentrations of cellular CA and enter the 
CA signaling pathway. We show here that modified LDL 
delivers a substantial amount of SM substrate for CA gener-
ation by human blood monocytes derived macrophages 
(HBMC) and stimulates CA formation from endogenous SM. 
2. Materials and methods 
2.1. Materials 
Human umbilical vein endothelial cells (EC, EndoPack-UV cell 
culture system), Clonetics (San Diego, CA); sphingomyelin phospho-
diesterase (E. coli, ~220 units/mg), Sigma (Deisenhofen, Germany); 
1,2-D AG-kinase (Bacillus cereus, 6.3 units/mg), Calbiochem (San Die-
go, CA); [y-32P]ATP (111 TBq/mM) Hartmann Analytic (Braun-
schweig, Germany); [3H]acetic anhydride (18.5 GBq/mM, 3.7 GBq/ 
ml) Amersham (Braunschweig, Germany); BODIPY-FL-C5-SM/CA, 
Molecular Probes (Eugene, OR); other reagents, Sigma and Fluka 
(Neu-Ulm, Germany). 
2.2. Cell culture 
HBMC were prepared by Ficoll-Paque density gradient centrifuga-
tion from venous blood of healthy male donors according to pub-
lished procedures [14,15] and cultured in RPMI 1640 medium supple-
mented with 10% heat inactivated FCS, glutamine (2 mM), and 
penicillin (100 units/ml), streptomycin (100 ug/ml) in a humidified 
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atmosphere (5% CO2 in air). The medium was changed daily. Non-
adherent cells were removed by washing with supplemented medium 
and resident cells were used after 6 days. Prior to experimentation 
cells were plated in 6-well plastic cell culture plates (3X106 cells/well) 
and incubated for 3 h. 
2.3. Preparation of LDL and modified LDL 
LDL was isolated from pooled human plasma as described [16] and 
processed further as outlined previously [5] ; all protein values refer to 
500 kDa (apoB). Acetylated LDL (acLDL) was prepared according to 
the method of Basu et al. [17], oxidized LDL (oxLDL) by exposure to 
copper at reported conditions [5]. EC-LDL was obtained by incuba-
tion of confluent endothelial cells with LDL (100 ug/ml) for 24 h as 
described by Auge et al. [18]. 
2.4. Synthesis of f3H-N-acetyl]sphingomyelin 
[3H-./V-Acetyl]sphingomyelin was synthesized from phosphoryl-
sphingosine (4 mg, 9 umol) and [3H]acetic anhydride (5.1 mg, 50 
umol, 18.5 GBq/mM (=3.7 GBq/ml toluene)) by reaction in toluene 
(18 h, RT) in the presence of A^JV'-dicyclohexylcarbodiimide (41 mg, 
200 umol), (7V,./V)-diethylamme (10 ul) and diethylaminopyridine (2.7 
mg, 20 umol). The mixture was then stirred (40°C, 1 h) with 2 ml 
KOH (0.2 M) and tetrabutylammoniumhydroxide (cat.) to cleave ace-
tyl esters, the organic phase separated, the aqueous phase extracted 
(chloroform, 3 x 3 ml) and the combined organic phases purified by 
silica gel chromatography (5 cm3 silica gel grade 60, 70-230 mesh, 
elution of unpolar side-products by 15 ml chloroform then elution of 
product with chloroform/methanol/water 30:20:5, v/v (in the 15-20 
ml fraction)). Further purification was achieved by TLC chromatog-
raphy (0.5 mm plates) in the same eluent, scraping of the correspond-
ing radioactive spot identified by nonradioactive standard and meth-
anol extraction (3x4 ml). The product (1.5 mg, 2.96 uM, 9.2 GBq/ 
mM, 33% yield referring to phosphorylsphingosine) was homogeneous 
in the above mentioned TLC system and showed a radioactive purity 
of >97%; identity was confirmed by FAB-mass spectroscopy. 
2.5. Labeling of LDL with [3H-N-acetyl]sphingomyelin and 
BODIPY-FL-d-sphingomyelin 
Labeled SM ([3H-7V-acetyl]SM or BODIPY-FL-C5-SM) was dis-
solved in chloroform (1 mg/ml); 10 u.1 of this solution was dried in 
a stream of nitrogen, sonicated (2 min, 4°C) in 100 ul Tris-HCl buffer 
(pH 7.5, 10 mM) and added to LDL or acLDL (1 ml, 1.28 mg). The 
mixture was treated (2 h, 37°C) with a plasma fraction as described 
[19] to catalyze the incorporation of labeled phospholipids. Labeled 
LDL was obtained after reisolation by density gradient centrifugation 
and dialysis at the above mentioned conditions. Result of a typical 
experiment: [3H-W-acetyl]SM-LDL 95.7 kBq/mg, [3H]SM-oxLDL 
107.2 kBq/mg, [3H]SM-acLDL 133.9 kBq/mg. In any preparation, 
the content of incorporated labeled SM in the lipoprotein was 
< 2 % of the natural content of SM (average value 181 ±32 mole-
cules/particle (LDL concentration calculated on the basis of 500 
kDa protein)); agarose gel electrophoresis indicated that lipoproteins 
labeled with [3H-W-acetyl]SM or BODIPY-FL-C5-SM migrated at the 
same position as the untreated particles. 
2.6. Sphingomyelinlceramide assays and sphingomyelinase activity 
The total concentration of internalized/cell-associated ceramide was 
determined from cell extracts (treated with 30 ul 0.2 M KOH, 1 h, 
37°C to hydrolyse DAG/esters) as [32P]ceramidephosphate after incu-
bation with [y-32P]ATP/DAG-kinase, subsequent extraction, TLC sep-
aration, scraping of phospholipids identified by standards and quan-
titation by counting of Cerenkov radiation (or by liquid scintillation 
counting when [3H-./V-acetyl]SM-lipoproteins were used) as described 
[20]; [3H]C2-CA, [
3H]SM content in cells (after incubation with [3H-
7V-acetyl]SM-(ox/ac)LDL) is calculated as JV-acetyl(phospho)lipid 
based on the respective specific activity of [3H]SM in the lipoprotein, 
referring to an average SM content of 181 ±32 molecules/particle in 
the lipoproteins. The DAG-kinase method was also used for determi-
nation of SM in cells and CA/SM in lipoproteins (CA content was 
s 6% in LDL oxidized by Cu2+ or EC, data are corrected with free 
(LDL-associated) CA present in the medium), SM content was as-
sayed after incubation with SMase (approximately 40 mU/ml, 2 h, 
37°C in buffer for neutral SMase as described [21] and data correction 
with CA values obtained without SMase treatment). BODIPY-FL-C5-
SM/CA concentration was determined after extraction and TLC sep-
aration at conditions outlined above, quantitation (a calibration curve 
was prepared) was obtained by fluorescence photometry (A.EX 503 nm, 
E^m 509 nm in methanol) after scraping of fluorescent spots and 
extraction with 3 X 5 ml of chloroform/methanol 2:1. Selective deter-
mination of the neutral/acidic SMase activity in cells was performed 
with [3H]C2-ceramide as a substrate at conditions described by Wieg-
mann et al. [21]. 
2.7. Fluorescence microscopy 
Cells were treated with BODIPY-FL-C5-SM-labeled lipoproteins 
(27 u.g/ml, 1 h), washed three times with PBS (pH 7.4) and placed 
under a microscope (confocal laser-scanning microscope DM RB/E; 
Kr-line, -^EX 568 nm, l_E,n 602 nm with image documentation TCS4D ; 
Leica, Bensheim, Germany). 
3. Results 
3.1. Uptake of phospholipids from [3H-N-acetyl]sphingo-
myelinlBODIP Y-FL- C5 -sphingomyelin-labeled LDL 
In order to trace SM in lipoproteins and cells, LDL and 
acetylated LDL were labeled with [3H-Ar-acetyl]SM or with 
BODIPY-FL-C5-SM by means of plasma transfer proteins. 
After addition of [3H]/BODIPY-FL-C5-SM-labeled lipopro-
tein, the internalized/cell-bound label was quantitated. As 
shown in Table 1, modification of the LDL particle by oxi-
dation or acetylation is followed by an enhanced uptake of 
3H-labeled (phospho)lipid from the particle. In comparison 
with [3H]SM-LDL, 63% more tritiated material was internal-
ized from [3H]SM-acLDL and 46% from [3H]SM-oxLDL 
after 1 h. About 4% of the total 3H-radioactivity present in 
[3H]SM-acLDL was found to be cell-associated already within 
5 min, 6% after 20 min and 8% after 40 min (not shown) 
suggesting a rapid (phospho)lipid transfer in the initial phase. 
A preincubation with the scavenger receptor competitor poly-
Table 1 
Uptake of 3H-labeled (phospho)lipids from [3H-JV-acetyrjSM lipoproteins and effect on sphingomyelinase activity 
[3H]Lipoprotein Uptake (%) Sphingomyelinase activation (fold) 
neutral acidic 
LDL 
oxLDL 
acLDL 
acLDL+Poly I (10 ug/ml) 
5.56 ±0.67 
8.12 ±0.97 
9.07 ±0.93 
3.87 ±0.72 
1.6 
3.5 
3.8 
2.1 
0.7 
1.8 
0.8 
1.1 
Human macrophages (3X 106) were incubated with [3H]SM-LDL (27 ug/ml, 1 h) or pretreated with polyinosinic acid (10 ug/ml, 30 min, washed 
(3 X ) with medium prior to the addition of the lipoprotein). The medium was removed, the cells were washed with precooled PBS and taken up into 
50 ul homogenization buffer containing 0.1% Triton [21]. Radioactivity was measured in the supernatant of broken cells after centrifugation (4 min, 
15000Xg, 4°C). The uptake of cell-associated 3H-labeled (phospho)lipid is calculated as percent [3H-JV-acetyl]SM, referring to the total radio-
activity added with the lipoprotein (= 100%); data are means of two experiments performed in triplicate. The change of neutral and acidic SMase 
activity (upon exposure to the respective LDL) is expressed relative to untreated controls (means of two experiments performed in duplicate, 
determined as described in Section 2). 
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Fig. 1. Cellular distribution of BODIPY-FL-C5-SM-labeled acLDL. Macrophages were treated with acLDL labeled with BODIPY-FL-C5-SM 
(1 h, 27 u,g/ml) and the distribution of fluorescent (phospho)lipids visualized by confocal laser scanning microscopy (1000-fold magnification, 
-^Ex 568 nm, X^m 602 nm); fluorescent (phospho)lipids are localized on the cell surface/membrane, a granular staining is visible in the cyto-
plasm; typical result of three independent experiments. 
inosinic acid (or fucoidan, 10 |Xg/ml, not shown) reduced the 
uptake of tritiated (phospho)lipid approximately to values 
obtained with [3H]SM-acLDL. 
Labeling with fluorescent BODIPY-FL-C5-SM-LDL/ 
acLDL was used to observe the cellular distribution of lip-
oprotein-bound (phospho)lipids in the cells. After 1 h incuba-
tion with 27 |4,g/ml modified lipoprotein, fluorescent com-
pounds were distributed in the cell membrane as well as 
into intracellular compartments (Fig. 1). Distribution and rel-
ative intensity of the internalized/cell-bound fluorescence after 
addition of BODIPY-FL-C5-SM-acLDL could not be distin-
guished from the partitioning of fluorescence obtained after 
incubation with a corresponding BODIPY-labeled LDL prep-
aration. 
3.2. Metabolism of LDL-sphingomyelin 
HBMC were treated with [3H-A^-acetyl]SM-LDL, -acLDL, 
-oxLDL or the corresponding BODIPY-FL-C5-SM-labeled 
lipoproteins (all 27 |xg/ml) to examine the metabolism of 
SM derived from lipoproteins. The cells were washed, ex-
tracted and the labeled (phospho)lipids quantitated by liquid 
scintillation counting or fluorescence photometry after TLC 
separation. We observed that most of the (cell-associated) 
tritiated material was located in the [3H]C2-CA fraction 
(69 ±17% after addition of acLDL, 65 ±15% after addition 
of oxLDL, average values from three experiments), residual 
[3H]SM added up to 9 ± 6% of the total radioactivity admin-
istered (not shown). According to the data depicted in Fig. 2, 
exogenous (initially lipoprotein-bound) SM was converted to 
ceramide to give 210 pmol [3H]C2-CA/10
6 cells (acLDL) or 93 
pmol/106 cells (LDL). Comparable results were obtained 
when BODIPY-FL-C5-SM-labeled LDL/acLDL was exam-
ined and BODIPY-FL-C5-SM/CA analyzed by fluorometry 
(not shown). An increase in the [3H]SM-acLDL concentration 
produced a concomitant rise in [3H]C2-CA which leveled off 
at a lipoprotein concentration of about 150 (J,g/ml (resulting in 
~400 pmol CA/106 cells) indicating apparent saturation of 
uptake/cell association and/or enzymatic hydrolysis (Fig. 2, 
inset). 
3.3. Effects of lipoproteins on cellular ceramide concentration 
and sphingomyelinase activity 
Besides the portion of ceramide provided by the cleavage of 
LDL-SM, the level of CA derived from intracellular substrate 
(basal level 140 pmol/106 cells) was found to be increased after 
exposure to modified LDL (43% by acLDL, 35% by oxLDL; 
Fig. 3) and accompanied by a parallel decrease of SM from 
420 to 360 pmol/106 cells (after acLDL treatment); the effect 
of LDL was marginal (~5%). The oxLDL-mediated effect 
was not restricted to lipoprotein prepared by Cu2+-initiated 
in vitro oxidation as EC-LDL changed the percentage of CA 
similarly (Fig. 3). A significant reduction of the lipoprotein-
induced SM hydrolysis (increase by 19%>) was observed when 
the macrophages were incubated with polyinosinic acid prior 
to the addition of acLDL (Fig. 3). When the activity of the 
cleaving enzymes, the SMase, was assayed after the lipopro-
acLDL oxLDL LDL 
Fig. 2. Ceramide generation from lipoprotein derived sphingomyelin. 
Macrophages (3X106) were treated with [3H-N-acetyl]SM-LDL, 
-acLDL or -oxLDL (60 min, 27 |xg/ml), washed with PBS and bro-
ken by repeated freeze-thawing. Lipids were extracted and the 
amount of [3H]C2-CA determined after phosphorylation with DAG-
kinase/[y-32P]ATP and TLC separation as described in Section 2. 
The dependence of the formation of [3H]C2-CA on the [3H-7V-ace-
tyl]SM-LDL concentration is given in the inset. The data corre-
spond to means ± S.E. of 3 separate experiments. 
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Fig. 3. Formation of ceramide from endogenous sphingomyelin in 
response to lipoprotein treatment. Ceramide concentration was 
measured after extraction of lipids, phosphorylation with DAG-kin-
ase/[y-32P]ATP and TLC separation; the values represent the in-
crease of ceramide (basal level 140 pmol/106 cells) found after incu-
bation of cells with the lipoproteins (1 h, 27 ug/ml) and are 
corrected by the corresponding [3H]C2-CA values derived from 
exogenous (lipoprotein-associated) SM as determined with [3H-iV-
acety]SM-labeled lipoproteins. The open bar gives the value ob-
tained with EC-LDL (27 ug/ml). Results are given as means ±S.E. 
(" = 3). 
tein treatment we found that the modified particles enhanced 
the activity of the neutral SMase by 280% (acLDL) and 250% 
(oxLDL) whereas the activity of the acidic SMase was only 
affected by the oxLDL treatment (+80%>), a slight inhibition 
was noted after exposure to ac- or native LDL (Table 1). For 
either enzyme, the acLDL-induced change was markedly re-
duced by treatment with polyinosinic acid. 
4. Discussion 
Our results demonstrate that most of the sphingomyelin 
originating from LDL, acLDL or oxLDL undergoes conver-
sion to ceramide by HBMC. The amount of ceramide pro-
duced depends on the lipoprotein concentration, correlates 
with the percentage of labeled material found cell-associated 
and coincides with a concomitant stimulation of SMase activ-
ity. Fluorescence microscopy provides evidence for the incor-
poration of LDL-SM into the acceptor membrane (an obser-
vation also made with platelets [22]) as well as into cytosolic 
compartments. In fact, Lipsky and Pagano [23,24] have shown 
that fluorescently tagged ceramides accumulate in the Golgi 
apparatus. 
LDL modification increased the yield of ceramide produced 
from LDL-SM, an observation which could be explained by 
an enhancement of (phospho)lipid transfer from SR-bound 
particles and/or by an increased internalization/degradation. 
Conversely, a reduction of cell-associated CA was caused by 
pretreatment with the scavenger receptor competitors polyino-
sinic acid and fucoidan. However, although internalization of 
LDL-apolipoprotein is enhanced by modification [25], parti-
tioning of LDL-phospholipids into the membrane of platelets 
apparently did not require endocytosis and lipid transfer was 
markedly faster than protein-cell association [22]. These data 
favor (phospho)lipid transfer rather than particle internaliza-
tion. Besides scavenger receptor binding via modified apolipo-
protein, stimulation of SMase(s) by modified lipoproteins may 
in turn increase aggregation and cell association [26,27]. 
Our current data indicate that the proportion of ceramide 
attributable to a cleavage of LDL-SM clearly exceeds that 
produced from endogenous substrate. When extracellularly 
bound 3H-labeled acLDL was removed after 1 h by addition 
of an (15-fold) excess of unlabeled lipoprotein, cell-associated 
3H-radioactivity was reduced by 22% (R. Claus, personal 
communication) resulting in a ratio of 2.7:1 as for CA from 
exogenous/CA from endogenous SM (acLDL-derived CA di-
minished by 22%o). Consistently, a significant amount of the 
diffusible metabolite CA may enter signalling pathways, even 
if cell-associated ceramide retained after washing may not 
completely be integrated into cellular compartments. 
Auge and colleagues have shown that oxLDL induces SM 
hydrolysis in smooth muscle cells [18], a process which is 
accompanied by a decrease of the SM level and an increase 
of the CA level. Neutral SMase, an enzyme which resides at 
the membrane (although a Mg2+-independent form has been 
identified in the cytosol as well [28]), is primarily activated by 
(modified) LDL and certainly contributes to LDL-SM cleav-
age. On the other hand, modified lipoprotein internalized via 
scavenger receptors is prone to degradation within lysosomes, 
and LDL-SM is thus a potential substrate of the acidic lyso-
somal SMase, compatible with the mtracellular location of 
(initially lipoprotein-bound) BODIPY-FL-Cs-labeled (phos-
pho)lipids. The acidic enzyme was stimulated by oxLDL treat-
ment, not by acLDL which may be due to differences in the 
binding/uptake of the lipoproteins [29] and/or could reflect a 
distinct impact on redox-regulated processes. Accordingly, 
modified LDL is in principle capable of providing substrate 
for both neutral and acidic SMase, although, as concluded 
from activity changes, the role of the first mentioned enzyme 
may be more important. This issue however deserves further 
examination and Wiegmann et al. [21] have pointed out signal 
transduction by ceramide is dependent on the topology of 
formation and different pathways are controlled by distinct 
SMase activities. In this context, it is of note that Schütze 
and colleagues [30] and others [31] have suggested that acidic 
SMase can be activated by 1,2-DAG at the membrane; an 
induction of DAG increase by oxLDL in murine macrophages 
has been recently reported by us [5]. 
The results of our study show for the first time that in 
human macrophages LDL, in particular modified LDL, deliv-
ers SM substrate for CA generation, stimulates SMase activity 
and induces cleavage of cellular SM. A recent study states that 
retained lesional LDL accumulates ceramide [27], supporting 
the notion that our observations could have pathophysiolog-
ical implications. Ceramide from lipoprotein sources may be 
involved in a number of regulatory events such as the induc-
tion of cyclooxygenase expression [32] and/or activation of 
MAP kinases [33,34], both effects observed with modified 
LDL [5,6]. It is now a matter of great interest to examine 
which of the various events induced by modified LDL in 
macrophages might be assigned to alterations in the SM-CA 
pathway. 
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